Opendata, web and dolomites

His-Li mouse

His-Li mouse, the unique humanized mouse model resembling human liver and immune systems

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 His-Li mouse project word cloud

Explore the words cloud of the His-Li mouse project. It provides you a very rough idea of what is the project "His-Li mouse" about.

13    millions    market    reveal    offers    total    sound    reaching    efficient    validation    humanized    first    generation    representing    reflects    perform    metabolism    chain    models    least    mouse    toxicity    feasibility    immune    lies    faster    experimental    li    transcure    strikingly    efficacy    humans    quality    clinical    costly    potentially    programs    supply    single    fail    lack    mice    global    liver    unexpected    tool    deadly    subsequently    optimise    fact    rate    discovery    save    perfectly    customers    adme    safe    benefit    combination    accurate    pharmaceutical    toxicology    reflect    safety    bioservices    pharmaceuticals       trials    21    toxic    protocol    population    human    drug       critical    drugs    70    iterations    service    strategy    prospect    breakthrough    eliminate    approved    tests    evaluation    humanization    unnecessary    validate    excretion    innovation    preclinical    unpredictably    physiology    absorption    model    accounting    lives    plans    reduce   

Project "His-Li mouse" data sheet

The following table provides information about the project.

Coordinator
TRANSCURE BIOSERVICES SAS 

Organization address
address: BIOPARK LE FORUM 1 260 AVENUE MARI
city: ARACHAMPS
postcode: 74160
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website https://www.transcurebioservices.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TRANSCURE BIOSERVICES SAS FR (ARACHAMPS) coordinator 50˙000.00

Map

 Project objective

Preclinical toxicology evaluation is the most critical step in pharmaceutical drug development, representing about 21.2% of the total drug development costs. About 70% of drug development programs fail due to toxicity or unexpected issues in Absorption, Distribution, Metabolism, and Excretion (ADME) at Phase 1 validation on humans. The main problem lies on the lack of accurate and reliable pre-clinical mouse models: in fact, current models fail to reflect human liver physiology, and often lead to the development of drugs that are safe in mice, and reveal unpredictably toxic or even deadly in humans. Strikingly, only 13.8% of drugs development programs are finally approved. The development of a single drug requires at least 1,000 iterations, accounting for about €10 M in total, and procedures that can take up to 10 years. TransCure bioServices offers the His-Li-mouse, a humanized mouse model for pre-clinical drug testing, based on the unique combination of the humanized liver and immune systems. His-Li-mouse is the first pre-clinical model that perfectly reflects the human liver physiology and immune response, thus representing a unique tool to perform reliable pre-clinical safety and efficacy tests of drugs. His-Li-mouse enables to reduce the failure rate observed when reaching the clinical trials and to subsequently eliminate unnecessary and costly experimental iterations. This will benefit to the global population, as a more efficient drug development process will potentially save millions of lives or improve its quality by enabling the faster discovery of breakthrough pharmaceuticals. During the phase 1 feasibility study, TransCure will establish a sound go-to-market strategy and supply chain, and will draft further development plans. During the innovation project, TransCure will optimise the humanization protocol, scale-up mice generation and validate the His-Li-mouse pre-clinical service with prospect customers.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HIS-LI MOUSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HIS-LI MOUSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Presque (2019)

Smart Nursing Bra

Read More